ALT Kaplan\u2013Meier estimates of disease-free survival by treatment group in the intention-to-treat population. Median follow-up was 64 months (IQR 50\u201375). HR=hazard ratio. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.

ALT This image is a detailed infographic on standard-of-care testing and long-read genome sequencing as first-tier approaches to genetic testing. It includes an assessment of diagnostic samples, diagnostic yield, concordance according to variant type, and diagnostic yield.

ALT This image is from a Research Summary published in the New England Journal of Medicine about decompression with or without duraplasty for Chiari I and syringomyelia. It includes a diagram of the brain highlighting Chiari I and syringomyelia, information about study participants, and images comparing two groups: PFD with duraplasty and PFD alone. Participants included 162 children with an average age of 10 years; 54% are noted as female, and 46% as male. The images indicate the sample sizes for each group: 78 for PFD with duraplasty and 84 for PFD alone. A prompt invites readers to view the full Research Summary at NEJM.org.

ALT Stacked bars indicating the durations of the laboratory, Xpandomer synthesis, sequencing and primary-analysis steps, and secondary-analysis steps, with the start time normalized to hour 0.

ALT Radial plot bars indicating the wall-clock timing for each of the prospective cases, including transport time, laboratory processing and sequencing, and time for tertiary analysis and report generation.